Jagsonpal Pharmaceuticals has received full consideration of Rs. 41 crore towards the sale of the facility and will now be proceeding with registration formalities
The FDA conducted a comprehensive Pre-Approval Inspection (PAI) and cGMP audit
US Generics grew 5% to Rs. 467 Crores for the quarter
The inspection concluded with the issuance of Form 483 with four observations which are procedural in nature
Mylan and Novo Nordisk reach settlement of US patent litigation related to Ozempic
The inspection concluded with the issuance of a form 483 with five observations
Lupin's Pithampur Unit-1 gets Form 483 from USFDA with 3 observations
Glenmark Pharmaceuticals Limited has informed that the USFDA has issued Form 483 with zero observations
USFDA concludes inspection of Dr. Reddy's Laboratories R&D centre in Bachupally with zero observation
The drugmaker's net profit slipped 26 per cent on-year to Rs 143.8 crore
Subscribe To Our Newsletter & Stay Updated
